267 related articles for article (PubMed ID: 37736880)
21. A Novel Triphenylphosphonium Carrier to Target Mitochondria without Uncoupling Oxidative Phosphorylation.
Kulkarni CA; Fink BD; Gibbs BE; Chheda PR; Wu M; Sivitz WI; Kerns RJ
J Med Chem; 2021 Jan; 64(1):662-676. PubMed ID: 33395531
[TBL] [Abstract][Full Text] [Related]
22. Mitochondria-Targeted Analogues of Metformin Exhibit Enhanced Antiproliferative and Radiosensitizing Effects in Pancreatic Cancer Cells.
Cheng G; Zielonka J; Ouari O; Lopez M; McAllister D; Boyle K; Barrios CS; Weber JJ; Johnson BD; Hardy M; Dwinell MB; Kalyanaraman B
Cancer Res; 2016 Jul; 76(13):3904-15. PubMed ID: 27216187
[TBL] [Abstract][Full Text] [Related]
23. Targeting Mitochondrial OXPHOS and Their Regulatory Signals in Prostate Cancers.
Chen CL; Lin CY; Kung HJ
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948229
[TBL] [Abstract][Full Text] [Related]
24. Hyperactivation of oxidative mitochondrial metabolism in epithelial cancer cells in situ: visualizing the therapeutic effects of metformin in tumor tissue.
Whitaker-Menezes D; Martinez-Outschoorn UE; Flomenberg N; Birbe RC; Witkiewicz AK; Howell A; Pavlides S; Tsirigos A; Ertel A; Pestell RG; Broda P; Minetti C; Lisanti MP; Sotgia F
Cell Cycle; 2011 Dec; 10(23):4047-64. PubMed ID: 22134189
[TBL] [Abstract][Full Text] [Related]
25. Identification of a novel toxicophore in anti-cancer chemotherapeutics that targets mitochondrial respiratory complex I.
Stephenson ZA; Harvey RF; Pryde KR; Mistry S; Hardy RE; Serreli R; Chung I; Allen TE; Stoneley M; MacFarlane M; Fischer PM; Hirst J; Kellam B; Willis AE
Elife; 2020 May; 9():. PubMed ID: 32432547
[TBL] [Abstract][Full Text] [Related]
26. Repurposing atovaquone: targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells.
Fiorillo M; Lamb R; Tanowitz HB; Mutti L; Krstic-Demonacos M; Cappello AR; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
Oncotarget; 2016 Jun; 7(23):34084-99. PubMed ID: 27136895
[TBL] [Abstract][Full Text] [Related]
27. Targeting Oxidative Phosphorylation Reverses Drug Resistance in Cancer Cells by Blocking Autophagy Recycling.
Lee JS; Lee H; Jang H; Woo SM; Park JB; Lee SH; Kang JH; Kim HY; Song J; Kim SY
Cells; 2020 Sep; 9(9):. PubMed ID: 32883024
[TBL] [Abstract][Full Text] [Related]
28. First-in-class candidate therapeutics that target mitochondria and effectively prevent cancer cell metastasis: mitoriboscins and TPP compounds.
Ózsvári B; Sotgia F; Lisanti MP
Aging (Albany NY); 2020 May; 12(11):10162-10179. PubMed ID: 32452826
[TBL] [Abstract][Full Text] [Related]
29. Triphenylphosphonium-conjugated glycol chitosan microspheres for mitochondria-targeted drug delivery.
Lee YH; Park HI; Chang WS; Choi JS
Int J Biol Macromol; 2021 Jan; 167():35-45. PubMed ID: 33227331
[TBL] [Abstract][Full Text] [Related]
30. Drugging OXPHOS Dependency in Cancer.
Cancer Discov; 2019 Aug; 9(8):OF10. PubMed ID: 31186236
[TBL] [Abstract][Full Text] [Related]
31. A review of the basics of mitochondrial bioenergetics, metabolism, and related signaling pathways in cancer cells: Therapeutic targeting of tumor mitochondria with lipophilic cationic compounds.
Kalyanaraman B; Cheng G; Hardy M; Ouari O; Lopez M; Joseph J; Zielonka J; Dwinell MB
Redox Biol; 2018 Apr; 14():316-327. PubMed ID: 29017115
[TBL] [Abstract][Full Text] [Related]
32. Targeting Mitochondrial Complex I Overcomes Chemoresistance in High OXPHOS Pancreatic Cancer.
Masoud R; Reyes-Castellanos G; Lac S; Garcia J; Dou S; Shintu L; Abdel Hadi N; Gicquel T; El Kaoutari A; Diémé B; Tranchida F; Cormareche L; Borge L; Gayet O; Pasquier E; Dusetti N; Iovanna J; Carrier A
Cell Rep Med; 2020 Nov; 1(8):100143. PubMed ID: 33294863
[TBL] [Abstract][Full Text] [Related]
33. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
34. Targeting STAT3 and oxidative phosphorylation in oncogene-addicted tumors.
Lee M; Hirpara JL; Eu JQ; Sethi G; Wang L; Goh BC; Wong AL
Redox Biol; 2019 Jul; 25():101073. PubMed ID: 30594485
[TBL] [Abstract][Full Text] [Related]
35. Micelles Loaded With Puerarin And Modified With Triphenylphosphonium Cation Possess Mitochondrial Targeting And Demonstrate Enhanced Protective Effect Against Isoprenaline-Induced H9c2 Cells Apoptosis.
Li WQ; Wu JY; Xiang DX; Luo SL; Hu XB; Tang TT; Sun TL; Liu XY
Int J Nanomedicine; 2019; 14():8345-8360. PubMed ID: 31695371
[TBL] [Abstract][Full Text] [Related]
36. Triphenylphosphonium derivatives disrupt metabolism and inhibit melanoma growth in vivo when delivered via a thermosensitive hydrogel.
Kloepping KC; Kraus AS; Hedlund DK; Gnade CM; Wagner BA; McCormick ML; Fath MA; Seol D; Lim TH; Buettner GR; Goswami PC; Pigge FC; Spitz DR; Schultz MK
PLoS One; 2020; 15(12):e0244540. PubMed ID: 33378390
[TBL] [Abstract][Full Text] [Related]
37. TPP-based conjugates: potential targeting ligands.
Batheja S; Gupta S; Tejavath KK; Gupta U
Drug Discov Today; 2024 Jun; 29(6):103983. PubMed ID: 38641237
[TBL] [Abstract][Full Text] [Related]
38. Targeting mitochondrial metabolism for metastatic cancer therapy.
Passaniti A; Kim MS; Polster BM; Shapiro P
Mol Carcinog; 2022 Sep; 61(9):827-838. PubMed ID: 35723497
[TBL] [Abstract][Full Text] [Related]
39. A traditional gynecological medicine inhibits ovarian cancer progression and eliminates cancer stem cells via the LRPPRC-OXPHOS axis.
Jiang R; Chen Z; Ni M; Li X; Ying H; Fen J; Wan D; Peng C; Zhou W; Gu L
J Transl Med; 2023 Jul; 21(1):504. PubMed ID: 37496051
[TBL] [Abstract][Full Text] [Related]
40. Crosstalk between oxidative phosphorylation and immune escape in cancer: a new concept of therapeutic targets selection.
Qiu X; Li Y; Zhang Z
Cell Oncol (Dordr); 2023 Aug; 46(4):847-865. PubMed ID: 37040057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]